{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T12:20:50Z","timestamp":1779366050834,"version":"3.53.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008069","name":"University of California, San Francisco","doi-asserted-by":"publisher","award":["P30 EY002162"],"award-info":[{"award-number":["P30 EY002162"]}],"id":[{"id":"10.13039\/100008069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017433","name":"That Man May See","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017433","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK126070"],"award-info":[{"award-number":["DK126070"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["P30 EY002162"],"award-info":[{"award-number":["P30 EY002162"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["EY033859"],"award-info":[{"award-number":["EY033859"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["EY036139"],"award-info":[{"award-number":["EY036139"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["EY031372"],"award-info":[{"award-number":["EY031372"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["EY013574"],"award-info":[{"award-number":["EY013574"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.exer.2025.110346","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T03:44:17Z","timestamp":1742269457000},"page":"110346","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Lysophosphatidic acid receptor 3 (LPAR3) regulates ocular surface chloride transport via calcium signaling"],"prefix":"10.1016","volume":"255","author":[{"given":"Ethan S.","family":"Lindgren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongshan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yien-Ming","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livia","family":"de Souza Goncalves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feeling Y.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilda F.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan S.","family":"Verkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onur","family":"Cil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2327-5221","authenticated-orcid":false,"given":"Neel D.","family":"Pasricha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.exer.2025.110346_bib1","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1002\/art.40547","article-title":"Lysophosphatidic acid receptor 1 antagonist SAR100842 for patients with diffuse cutaneous systemic sclerosis: a double-blind, randomized, eight-week placebo-controlled study followed by a sixteen-week open-label extension study","volume":"70","author":"Allanore","year":"2018","journal-title":"Arthritis Rheumatol."},{"issue":"14","key":"10.1016\/j.exer.2025.110346_bib2","doi-asserted-by":"crossref","first-page":"6447","DOI":"10.1167\/iovs.16-20303","article-title":"Safety and efficacy clinical trials for SYL1001, a novel short interfering RNA for the treatment of dry eye disease","volume":"57","author":"Benitez-Del-Castillo","year":"2016","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.exer.2025.110346_bib3","doi-asserted-by":"crossref","first-page":"C231","DOI":"10.1152\/ajpcell.00175.2008","article-title":"Rho-family GTPases modulate Ca(2+) -dependent ATP release from astrocytes","volume":"295","author":"Blum","year":"2008","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"1","key":"10.1016\/j.exer.2025.110346_bib4","doi-asserted-by":"crossref","DOI":"10.1136\/bmjophth-2021-000709","article-title":"Economic burden and loss of quality of life from dry eye disease in Canada","volume":"6","author":"Chan","year":"2021","journal-title":"BMJ Open Ophthalmol."},{"issue":"3","key":"10.1016\/j.exer.2025.110346_bib5","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1089\/jop.2019.0087","article-title":"Nanomolar potency aminophenyltriazine CFTR activator reverses corneal epithelial injury in a mouse model of dry eye","volume":"36","author":"Chen","year":"2020","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"key":"10.1016\/j.exer.2025.110346_bib6","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/7542929","article-title":"Review: the lacrimal gland and its role in dry eye","volume":"2016","author":"Conrady","year":"2016","journal-title":"J. Ophthalmol."},{"issue":"3","key":"10.1016\/j.exer.2025.110346_bib7","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","article-title":"TFOS DEWS II definition and classification report","volume":"15","author":"Craig","year":"2017","journal-title":"Ocul. Surf."},{"issue":"10","key":"10.1016\/j.exer.2025.110346_bib8","doi-asserted-by":"crossref","first-page":"8402","DOI":"10.1007\/s12035-024-04108-5","article-title":"LPAR6 participates in neuropathic pain by mediating astrocyte cells via ROCK2\/NF-\u03baB signal pathway","volume":"61","author":"Fan","year":"2024","journal-title":"Mol. Neurobiol."},{"issue":"11","key":"10.1016\/j.exer.2025.110346_bib9","doi-asserted-by":"crossref","first-page":"4506","DOI":"10.1167\/iovs.17-22525","article-title":"Pro-Secretory activity and pharmacology in rabbits of an aminophenyl-1,3,5-triazine CFTR activator for dry eye disorders","volume":"58","author":"Felix","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"5","key":"10.1016\/j.exer.2025.110346_bib10","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1096\/fj.201500180","article-title":"Small-molecule CFTR activators increase tear secretion and prevent experimental dry eye disease","volume":"30","author":"Flores","year":"2016","journal-title":"FASEB J."},{"issue":"14","key":"10.1016\/j.exer.2025.110346_bib11","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1007\/s40265-022-01782-4","article-title":"Varenicline solution nasal spray: a review in dry eye disease","volume":"82","author":"Frampton","year":"2022","journal-title":"Drugs"},{"key":"10.1016\/j.exer.2025.110346_bib12","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jtos.2021.02.007","article-title":"The ocular surface immune system through the eyes of aging","volume":"20","author":"Galletti","year":"2021","journal-title":"Ocul. Surf."},{"issue":"1","key":"10.1016\/j.exer.2025.110346_bib13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41392-020-00367-5","article-title":"Role of lysophosphatidic acid and its receptors in health and disease: novel therapeutic strategies","volume":"6","author":"Geraldo","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.exer.2025.110346_bib14","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.exer.2013.07.027","article-title":"Tear film mucins: front line defenders of the ocular surface; comparison with airway and gastrointestinal tract mucins","volume":"117","author":"Hodges","year":"2013","journal-title":"Exp. Eye Res."},{"issue":"10","key":"10.1016\/j.exer.2025.110346_bib15","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1007\/s10792-022-02320-7","article-title":"Dry eye syndrome: comprehensive etiologies and recent clinical trials","volume":"42","author":"Huang","year":"2022","journal-title":"Int. Ophthalmol."},{"issue":"4","key":"10.1016\/j.exer.2025.110346_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25042315","article-title":"Lysophosphatidic acid receptor 3 activation is involved in the regulation of ferroptosis","volume":"25","author":"Huang","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.exer.2025.110346_bib17","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/nm1060","article-title":"Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling","volume":"10","author":"Inoue","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.exer.2025.110346_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.645834","article-title":"Structural and functional features of the P2X4 receptor: an immunological perspective","volume":"12","author":"Kanellopoulos","year":"2021","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.exer.2025.110346_bib19","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1167\/iovs.65.8.41","article-title":"High resolution images of human meibum spread on saline","volume":"65","author":"King-Smith","year":"2024","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2025.110346_bib20","first-page":"327","article-title":"P2Y2 receptor agonists for the treatment of dry eye disease: a review","volume":"8","author":"Lau","year":"2014","journal-title":"Clin. Ophthalmol."},{"issue":"3","key":"10.1016\/j.exer.2025.110346_bib21","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1021\/acs.jmedchem.6b01792","article-title":"Nanomolar-potency aminophenyl-1,3,5-triazine activators of the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel for prosecretory therapy of dry eye diseases","volume":"60","author":"Lee","year":"2017","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.exer.2025.110346_bib22","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00232-005-0849-1","article-title":"Aquaporins and CFTR in ocular epithelial fluid transport","volume":"210","author":"Levin","year":"2006","journal-title":"J. Membr. Biol."},{"issue":"4","key":"10.1016\/j.exer.2025.110346_bib23","doi-asserted-by":"crossref","first-page":"C1065","DOI":"10.1152\/ajpcell.1998.274.4.C1065","article-title":"Growth factor-like phospholipids generated after corneal injury","volume":"274","author":"Liliom","year":"1998","journal-title":"Am. J. Physiol."},{"issue":"21","key":"10.1016\/j.exer.2025.110346_bib24","doi-asserted-by":"crossref","first-page":"17608","DOI":"10.1074\/jbc.M111.330183","article-title":"Targeted deletion of LPA5 identifies novel roles for lysophosphatidic acid signaling in development of neuropathic pain","volume":"287","author":"Lin","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.exer.2025.110346_bib25","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s40135-022-00295-3","article-title":"Ocular surface ion transport and dry eye disease","volume":"10","author":"Lindgren","year":"2022","journal-title":"Curr. Ophthalmol. Reports"},{"issue":"3","key":"10.1016\/j.exer.2025.110346_bib26","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cellsig.2015.12.005","article-title":"3-Iodothyronamine increases transient receptor potential melastatin channel 8 (TRPM8) activity in immortalized human corneal epithelial cells","volume":"28","author":"Lucius","year":"2016","journal-title":"Cell. Signal."},{"issue":"35","key":"10.1016\/j.exer.2025.110346_bib27","doi-asserted-by":"crossref","first-page":"24079","DOI":"10.1074\/jbc.M114.572503","article-title":"Structural determinants of the transient receptor potential 1 (TRPV1) channel activation by phospholipid analogs","volume":"289","author":"Morales-L\u00e1zaro","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.exer.2025.110346_bib28","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/13543784.2018.1457647","article-title":"Tivanisiran, a novel siRNA for the treatment of dry eye disease","volume":"27","author":"Moreno-Monta\u00f1\u00e9s","year":"2018","journal-title":"Expet Opin. Invest. Drugs"},{"issue":"4","key":"10.1016\/j.exer.2025.110346_bib29","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.bbrc.2008.04.145","article-title":"Identification of the orphan GPCR, P2Y(10) receptor as the sphingosine-1-phosphate and lysophosphatidic acid receptor","volume":"371","author":"Murakami","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.exer.2025.110346_bib30","article-title":"Repurposing calcium-sensing receptor agonist cinacalcet for treatment of CFTR-mediated secretory diarrheas","volume":"6","author":"Oak","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.exer.2025.110346_bib31","author":"Ohta"},{"issue":"5","key":"10.1016\/j.exer.2025.110346_bib32","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.chest.2018.08.1058","article-title":"Randomized, double-blind, placebo-controlled, phase 2 trial of BMS-986020, a lysophosphatidic acid receptor antagonist for the treatment of idiopathic pulmonary fibrosis","volume":"154","author":"Palmer","year":"2018","journal-title":"Chest"},{"issue":"16","key":"10.1016\/j.exer.2025.110346_bib33","doi-asserted-by":"crossref","first-page":"27240","DOI":"10.18632\/oncotarget.15916","article-title":"Inhibition of lysophosphatidic acid receptor ameliorates Sj\u00f6gren's syndrome in NOD mice","volume":"8","author":"Park","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.exer.2025.110346_bib34","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jtos.2024.06.002","article-title":"Calcium-sensing receptor (CaSR) modulates ocular surface chloride transport and its inhibition promotes ocular surface hydration","volume":"34","author":"Pasricha","year":"2024","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.exer.2025.110346_bib35","series-title":"Encyclopedia of the Eye (2nd Edition)","article-title":"Corneal epithelium: transport and permeability","author":"Pasricha","year":"2024"},{"issue":"11","key":"10.1016\/j.exer.2025.110346_bib36","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1167\/tvst.9.11.20","article-title":"Ocular surface potential difference measured in human subjects to study ocular surface ion transport","volume":"9","author":"Pasricha","year":"2020","journal-title":"Transl. Vis. Sci. Technol."},{"issue":"2","key":"10.1016\/j.exer.2025.110346_bib37","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1167\/iovs.04-0528","article-title":"Characterization of growth and differentiation in a telomerase-immortalized human corneal epithelial cell line","volume":"46","author":"Robertson","year":"2005","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"4","key":"10.1016\/j.exer.2025.110346_bib38","doi-asserted-by":"crossref","first-page":"e412","DOI":"10.1111\/aos.13526","article-title":"Dry eye disease and oxidative stress","volume":"96","author":"Seen","year":"2018","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.exer.2025.110346_bib39","article-title":"Standardized measurement of nasal membrane transepithelial potential difference (NPD)","volume":"139","author":"Solomon","year":"2018","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.exer.2025.110346_bib40","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.survophthal.2016.02.006","article-title":"Is the main lacrimal gland indispensable? Contributions of the corneal and conjunctival epithelia","volume":"61","author":"Stevenson","year":"2016","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.exer.2025.110346_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.ynpai.2018.07.001","article-title":"Lysophosphatidic acid LPA1 and LPA3 receptors play roles in the maintenance of late tissue plasminogen activator-induced central poststroke pain in mice","volume":"5","author":"Ueda","year":"2019","journal-title":"Neurobiol. Pain"},{"issue":"5","key":"10.1016\/j.exer.2025.110346_bib42","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s40265-024-02031-6","article-title":"Recent United States developments in the pharmacological treatment of dry eye disease","volume":"84","author":"Valdes-Arias","year":"2024","journal-title":"Drugs"},{"key":"10.1016\/j.exer.2025.110346_bib43","first-page":"97","article-title":"The lacrimal gland and its veil of tears","volume":"13","author":"Walcott","year":"1998","journal-title":"News Physiol. Sci."},{"issue":"6","key":"10.1016\/j.exer.2025.110346_bib44","doi-asserted-by":"crossref","first-page":"C1646","DOI":"10.1152\/ajpcell.00323.2002","article-title":"Injury-elicited differential transcriptional regulation of phospholipid growth factor receptors in the cornea","volume":"283","author":"Wang","year":"2002","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"6 Pt 1","key":"10.1016\/j.exer.2025.110346_bib45","doi-asserted-by":"crossref","first-page":"C1385","DOI":"10.1152\/ajpcell.1995.269.6.C1385","article-title":"Lysophosphatidic acid, serum, and hyposmolarity activate Cl- currents in corneal keratocytes","volume":"269","author":"Watsky","year":"1995","journal-title":"Am. J. Physiol."},{"issue":"2","key":"10.1016\/j.exer.2025.110346_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygeno.2022.110286","article-title":"The Human Eye Transcriptome Atlas: a searchable comparative transcriptome database for healthy and diseased human eye tissue","volume":"114","author":"Wolf","year":"2022","journal-title":"Genomics"},{"issue":"2","key":"10.1016\/j.exer.2025.110346_bib47","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1167\/iovs.06-0203","article-title":"Lysophosphatidic acid promoting corneal epithelial wound healing by transactivation of epidermal growth factor receptor","volume":"48","author":"Xu","year":"2007","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"2","key":"10.1016\/j.exer.2025.110346_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10020250","article-title":"Topical TRPM8 agonist for relieving neuropathic ocular pain in patients with dry eye: a pilot study","volume":"10","author":"Yoon","year":"2021","journal-title":"J. Clin. Med."},{"issue":"7","key":"10.1016\/j.exer.2025.110346_bib49","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1194\/jlr.R046458","article-title":"LPA receptor signaling: pharmacology, physiology, and pathophysiology","volume":"55","author":"Yung","year":"2014","journal-title":"J. Lipid Res."},{"issue":"5","key":"10.1016\/j.exer.2025.110346_bib50","doi-asserted-by":"crossref","first-page":"C1089","DOI":"10.1152\/ajpcell.00523.2005","article-title":"Lysophosphatidic acid as a mediator for proinflammatory agonists in a human corneal epithelial cell line","volume":"291","author":"Zhang","year":"2006","journal-title":"Am. J. Physiol. Cell Physiol."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483525001174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483525001174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T04:10:39Z","timestamp":1778040639000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483525001174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":50,"alternative-id":["S0014483525001174"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2025.110346","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lysophosphatidic acid receptor 3 (LPAR3) regulates ocular surface chloride transport via calcium signaling","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2025.110346","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110346"}}